Natco Pharma's Stock Hits 52-Week High, Outperforms Sector and Sensex
Natco Pharma, a leading pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high of Rs.1584.65 on August 26, 2024. The company's stock is currently rated as a 'Buy' and has outperformed the sector by 0.81%. With a strong portfolio and impressive 1-year performance, Natco Pharma is poised for continued success in the market.
Natco Pharma, a leading pharmaceutical company in the largecap industry, has recently reached a new milestone. On August 26, 2024, the company's stock price hit a 52-week high, reaching Rs.1584.65. This positive development has caught the attention of investors and analysts alike.
According to MarketsMOJO, a leading stock analysis platform, Natco Pharma's stock is currently rated as a 'Buy'. The company has also been listed as part of MOJO Stocks on MarketsMOJO since July 3, 2023.
In terms of performance, Natco Pharma has outperformed the sector by 0.81% and has been on a consecutive gain for the last four days. In this period, the stock has risen by 8.98%. Additionally, the company's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.
Looking at the bigger picture, Natco Pharma has shown an impressive 1-year performance of 77.80%, compared to the Sensex's performance of 25.84%. This further solidifies the company's position as a top performer in the largecap industry.
Natco Pharma's success can be attributed to its strong portfolio of pharmaceutical products and its commitment to innovation and quality. With its consistent growth and positive outlook, the company is poised to continue its upward trajectory in the market.
Investors and stakeholders can be confident in Natco Pharma's potential for long-term success and growth in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
